Lilly has now submitted a new drug application (NDA) for orforglipron to the FDA for use in adults with obesity.
Eli Lilly stock hits a 90+ Quality score. BofA calls LLY underpriced, citing major growth ahead for its oral obesity drug.
At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Courtney Cameron, PharmD, BCACP, about tips for discussing supplement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback